| |
| |
|
| Insider
Information: |
Lilly Eli & Co |
| Relationship: |
10% Owner |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
17,228,056 |
|
|
Indirect Shares
|
2,568,543 |
|
|
| Direct
Value |
$1,634,192,970 |
|
|
|
Indirect Value
|
$1,542,924 |
|
|
| Total
Shares |
19,796,599 |
|
|
| Total
Value |
$1,635,735,894 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Icagen Inc |
ICGN |
10% Owner |
2005-02-08 |
300,340 |
2005-02-08 |
0 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
10% Owner |
2005-08-05 |
2,500,000 |
|
0 |
Premium* |
|
|
United Therapeutics Corp |
UTHR |
10% Owner |
2011-07-06 |
5,251,394 |
|
0 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
10% Owner |
2015-01-30 |
1,363,636 |
|
0 |
Premium* |
|
|
Aeglea Biotherapeutics, Inc. |
AGLE |
10% Owner |
2016-04-12 |
0 |
2016-04-12 |
2,568,543 |
Premium* |
|
|
Zymeworks Inc |
ZYME |
10% Owner |
2019-01-31 |
2,898,647 |
2018-08-02 |
0 |
Premium* |
|
|
Elanco Animal Health Inc |
ELAN |
10% Owner |
2019-03-11 |
0 |
2019-03-11 |
0 |
Premium* |
|
|
Avidity Biosciences, Inc. |
RNA |
|
2020-06-16 |
2,169,396 |
2020-06-16 |
0 |
Premium* |
|
|
Sigilon Therapeutics, Inc. |
SGTX |
10% Owner |
2020-12-08 |
2,744,443 |
2020-12-08 |
0 |
Premium* |
|
|
Prevail Therapeutics Inc. |
PRVL |
10% Owner |
2021-01-22 |
100 |
2021-01-22 |
0 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2022-11-30 |
100 |
2022-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZYME |
Zymeworks Inc |
10% Owner |
– – • |
2018-09-12 |
4 |
S |
$14.83 |
$149,175 |
D/D |
(10,059) |
3,894,318 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
10% Owner |
– – • |
2018-09-11 |
4 |
S |
$14.87 |
$167,689 |
D/D |
(11,277) |
3,904,377 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
10% Owner |
– – • |
2019-01-31 |
4 |
S |
$16.00 |
$4,000,000 |
D/D |
(250,000) |
2,898,647 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
10% Owner |
– – • |
2018-09-24 |
4 |
S |
$16.36 |
$33,162 |
D/D |
(2,027) |
3,848,647 |
0 |
- |
|
| SGTX |
Sigilon Therapeutics, Inc... |
10% Owner |
– – • |
2020-12-08 |
4 |
B |
$18.00 |
$5,400,000 |
D/D |
300,000 |
2,744,443 |
2.45 |
- |
|
| PRVL |
Prevail Therapeutics Inc. |
10% Owner |
– – • |
2021-01-22 |
4 |
B |
$22.50 |
$771,407,753 |
D/D |
34,284,789 |
100 |
2.45 |
- |
|
| UTHR |
United Therapeutics Corp |
10% Owner |
– – • |
2011-06-29 |
4 |
S |
$53.90 |
$5,066,115 |
D/D |
(93,991) |
6,111,940 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
10% Owner |
– – • |
2011-07-06 |
4 |
D |
$54.15 |
$43,939,638 |
D/D |
(811,443) |
5,251,394 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
10% Owner |
– – • |
2011-06-23 |
4 |
S |
$54.20 |
$5,189,271 |
D/D |
(95,743) |
6,111,940 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
10% Owner |
– – • |
2011-07-06 |
4 |
S |
$54.99 |
$2,700,174 |
D/D |
(49,103) |
5,251,394 |
0 |
- |
|
35 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
